| SATURDAY, JULY 21 |
| |
S2131 Patient Safety and Quality Assurance Symposium
Saturday, 1700-1930
|
|
Chair: Diponkar Banerjee, PHSA Laboratories, Vancouver, British Columbia
Click here for Objectives of this symposium
• Recognize latent factors that contribute to failures in anatomic pathology processes;
• Describe patient and system outcomes secondary to failures in anatomic pathology processes;
• Use mitigation strategies to decrease the frequency and the severity of harm of anatomic pathology failures.
-------------------------------------------
|
| 1700-1800 |
Quality Management in Anatomic Pathology: Case Studies, Analysis and Outcomes
Beverley A. Carter, Government of Newfoundland and Labrador, St. John’s, Newfoundland
|
| 1800-1900 |
Stephen Raab, Eastern Health Authority and Memorial University of Newfoundland, St. John’s, Newfoundland
|
| 1900-1930 |
Question and Answer Session with both speakers
|
| |
Back to top |
| |
|
S2132 Residents' Symposium
Saturday, 1800-1900
|
|
Chairs: Davinder Sidhu and Lik Hang Lee
|
| 1800-1900 |
Residents' Symposium
|
| 1900-2000 |
A casual dinner in a local restaurant will follow.
|
| |
Back to top |
| |
|
G2141 Biobanking SIG
Saturday, 2000-2200
|
|
Chair: Patricia Shaw, University Health Network, Toronto, Ontario
|
| |
Back to top |
| |
|
G2142 Informatics SIG
Saturday, 2000-2200
|
|
Chair: George Yousef, St. Michael’s Hospital, Toronto, Ontario
|
| |
Digital Pathology Education Fantasy or Reality
Aaron Pollett, Mount Sinai Hospital, Toronto, Ontario
|
| |
Image Analysis in Routine Pathology Practice: Are We There Yet
Christopher Naugler, Calgary Laboratory Services, Calgary, Alberta
|
| |
Informatics in Pathology Research: The Bridge to the Future
George M. Yousef, St. Michael’s Hospital, Toronto, Ontario
|
| |
Back to top |
| |
|
G2143 Education SIG
Saturday, 2000-2200
|
|
Chair: Jason Ford, Children’s and Women’s Health Centre of British Columbia, Vancouver, British Columbia
|
| |
Back to top |
| |
|
| SUNDAY, JULY 22 |
| |
S2231 Junior Scientist Award Lecture
Sunday, 1700-1745
|
|
|
|
Molecular Basis of Humoral Immunologic Rejection of Organ Transplants and Getting Ready for Molecular Precision Diagnostics for Transplants
Banu Sis, University of Alberta Hospital, Edmonton, Alberta
Click here for Objectives of this symposium
At the end of the session, the participants will:
• Understand why and how immune system rejects transplanted organs;
• Understand clinical and pathological phenotypes of transplant rejection, with a focus on antibody – mediated (humoral) rejection;
• Understand molecular mechanisms of humoral rejection, current diagnostic approach, and new diagnostic opportunities towards a personalized precision diagnostics.
-------------------------------------------
|
| |
Back to top |
| |
|
S2232 William Boyd Award Lecture
Sunday, 1745-1830
|
|
|
|
Going Viral
Richard Hegele, University of Toronto and the Hospital for Sick Children, Toronto, Ontario
Click here for Objectives of this symposium
At the end of the session, the participants will be able to:
• Summarize evidence that the human lung is not a sterile environment;
• Explain the role of viral infections in the pathogenesis of asthma and COPD;
• Explain the process of viral receptor discovery and validation for human respiratory syncytial virus.
-------------------------------------------
|
| |
Back to top |
| |
|
G2241 Guillermo Quinonez Seminar on the Medical Humanities SIG
Saturday, 2030-2230
|
|
Chair: Laurette Geldenhuys, QE II Health Sciences Centre, Halifax, Nova Scotia
|
| 2030-2130 |
Albert C. Broders’ Paradigm Shifts Involving the Prognostication and Definition of Cancer
James R. Wright, University of Calgary/Alberta Health Services, Calgary, Alberta
Click here for Objectives of this symposium
At the end of the session, the participants will be able to:
• Examine the history of tumors grading and staging;
• Describe the history of the concept of carcinoma in situ;
• Explore the role of Albert C. Broders and others in these discoveries.
-------------------------------------------
|
| 2130-2230 |
No Baby – No Nation – A History of Pediatrics and Pediatric Laboratory Science
Fergall Magee, IWK Health Centre, Halifax, Nova Scotia
Click here for Objectives of this symposium
At the end of the session, the participants will be able to:
• Appreciate the history childhood and children;
• Understand the changing approach to childhood disease from antiquity to modern times;
• Have an overview of the impact of pediatric laboratory science in improving health outcomes for children;
• Be aware of the threats to continued funding for pediatric health care in Canada.
-------------------------------------------
|
| |
Back to top |
| |
|
G2242 International Health SIG – Assisting the Development of Pathology in Low Resource Nations
Saturday, 2030-2230
|
|
Chair: Indroit Roy, McGill University, Montreal, Quebec
|
| |
Back to top |
| |
|
| MONDAY, JULY 23 |
| |
S2311 Hematological Pathology Symposium
Monday, 0800-1030
|
|
Chair: Marciano Reis, Sunnybrook Health Sciences Centre and University Health Network, Toronto, Ontario
|
| 0800-0900 |
Emina Torlakovic, University Health Network, Toronto, Ontario
|
| 0900-0930 |
Refreshment Break
|
| 0930-1030 |
Adnan Mansoor, Calgary Laboratory Services, Calgary, Alberta
|
| |
Back to top |
| |
|
S2312 Canadian Society of Cytopathology Symposium and Kulcsar Lecture
Monday, 0800-1030
|
|
Chair: Karim Khetani, University of Alberta, Calgary, Alberta
|
| |
Back to top |
| |
|
S2321 Dr. Cam Coady Slide Seminar: Dermatopathology
Monday, 1400-1700
|
|
Chair: Martin Trotter, Calgary Laboratory Services, Calgary, Alberta
|
|
Presenters: Dermatopathology Section, Calgary Laboratory Services, University of Calgary
|
|
Click here for Objectives of this slide seminar
At the end of the session, the participants will be able to:
• Diagnose twelve (12) important skin pathology diseases spanning inflammatory, infectious, neoplastic and infections conditions;
• Use the cases presented as triggers to review basic dermatopathology classification schemes and emerging concepts of skin diseases;
• Develop an approach to challenging skin pathology cases, including the use of ancillary testing and consultative second opinion.
-------------------------------------------
|
| 1400-1430 |
Duane Barber
|
| 1430-1500 |
Holly Brown
|
| 1500-1530 |
Refreshment Break
|
| 1530-1600 |
Andrea Bruecks
|
| 1600-1630 |
Kelly Guggisberg
|
| 1630-1700 |
Martin Trotter
|
| |
Back to top |
| |
|
| TUESDAY, JULY 24 |
| |
S2411 Anatomical Pathology Symposium
Tuesday, 0800-1130
|
|
Chairs: Alan Spatz, Jewish General Hospital and McGill University, Montreal, Quebec; Sylvia Asa, University Health Network, Toronto, Ontario
|
|
Click here for overview of this symposium
This symposium will present the most recent advances in the molecular pathology of lung tumours, breast pathology, gynecological tumours, thyroid neoplasms and melanomas, in putting emphasis on the correlations between phenotypic findings and genotypic information.
-------------------------------------------
Click here for Objectives of this symposium
At the end of the session, the participants will:
• Better understand the recent discoveries made in the biology of these diseases;
• Improve their ability to prescribe appropriate molecular pathology tests;
• Better understand the current unmet needs and research orientation in these fields.
-------------------------------------------
|
| 0805-0840 |
Recent Advances in Lung Tumours
Ming-Sound Tsao, Toronto General Hospital, Toronto, Ontario
Click here for Objectives of this session
At the end of the session, the participants will be able to:
• Recent changes in the classification of lung adenocarcinoma;
• Recent discoveries on oncogenic drivers in lung cancers and their therapeutic implications;
• Role of pathologists in the diagnosis and management of lung cancer.
-------------------------------------------
|
| 0840-0915 |
Recent Advances in Breast Pathology
Anna Marie Mulligan, St. Michael’s Hospital, University of Toronto, Toronto, Ontario
Click here for Objectives of this session
At the end of the session, the participants will be able to:
• Describe the current approach to the molecular classification of breast cancer;
• Compare the various multigene predictors currently available and how they relate to traditional prognostic parameters;
• Discuss the impact of molecular advancements on the management of patients with breast cancer.
-------------------------------------------
|
| 0915-0950 |
Recent Advances in Gynecological Tumours
Blaise Clarke, University Health Network, Toronto, Ontario
Click here for Objectives of this session
At the end of the session, the participants will be able to:
• Recent developments in classification of ovarian cancer subtypes and molecular, prognostic, predictive and genetic predilection correlation with subtypes;
• Controversies in typing and grading of endometrial cancer and the role of the pathologist in identifying Lynch syndrome;
• Role and significance of HPV in vulvar squamous cell carcinoma.
-------------------------------------------
|
| 0950-1020 |
Refreshment Break
|
| 1020-1055 |
Recent Advances in Thyroid Neoplasms
Sylvia Asa, University Health Network, Toronto, Ontario
Click here for Objectives of this session
At the end of the session, the participants will be able to:
• Understand the molecular changes that are associated with thyroid proliferative diseases;
• Describe the role of molecular testing in the diagnosis of thyroid nodules;
• Determine the impact of molecular testing on the management of patients with thyroid cancer.
-------------------------------------------
|
| 1055-1130 |
Recent Advances in Melanoma
Alan Spatz, Jewish General Hospital and McGill University, Montreal, Quebec
Click here for Objectives of this session
At the end of the session, the participants will be able to:
• Better understand the recent discoveries made in the biology of melanoma;
• Improve their ability to prescribe appropriate molecular pathology tests;
• Better understand the current unmet needs and research orientation in the melanoma field.
-------------------------------------------
|
| |
Back to top |
| |
|
S2412 Pediatric and Perinatal Symposium
Tuesday, 0800-1130
|
|
Chair: Fergall Magee, IWK Health Centre, Halifax, Nova Scotia
|
|
Click here for overview of this symposium
This symposium will offer a ‘state of the art’ update addressing aspects of pediatric cancer diagnosis. Attendees will review recent advances in the understanding of tumor biology and its impact on diagnostic and therapeutic algorithms, largely achieved through the efforts of the Children’s Oncology Group (COG). These efforts have resulted in more accurate diagnosis, the development of ‘novel’ agents, and a ‘risk stratification’ approach to therapy based on both patient and tumor signature. The session will present successes from the area of Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma and will highlight also the need for continued improvement by referring to cancer outcomes in adolescents and young adults [AYAs].
-------------------------------------------
|
| 0800-0900 |
Acute Lymphoblastic Leukemia in the Pediatric Population
Jason Ford, BC Childrens Hospital, Vancouver, British Columbia
Click here for Objectives of this presentation
At the end of the session, the participants will be able to:
• Summarize current concepts in the diagnosis and management of pediatric Acute Lymphoblastic Leukemias;
• Outline recent advances in the understanding of the molecular pathogenesis of pediatric acute lymphoblastic leukemia;
• Describe the significance of laboratory monitoring in pediatric ALL, including minimal residual disease testing by flow cytometry.
-------------------------------------------
|
| 0900-0930 |
Refreshment Break
|
| 0930-1030 |
Diagnosis and Therapeutic Approaches to Childhood Non-Hodgkin Lymphoma: Update from the Children’s Oncology Group
Megan Lim, University of Michigan, Ann Arbour, Michigan
Click here for Objectives of this presentation
At the end of the session, the participants will be:
• Familiar with common types of NHL that occur in childhood and young adolescents;
• Familiar with recent advances in pathophysiologic mechanisms in childhood and young adolescent NHL;
• Familiar with Novel treatments for NHL in childhood and young adolescents.
-------------------------------------------
|
| 1030-1130 |
Cancer in Adolescents and Young Adults [AYAs]
Fergall Magee, IWK Health Centre, Halifax, Nova Scotia
Click here for Objectives of this presentation
At the end of the session, the participants will:
• Understand the concept of Adolescent/Young Adult (AYA);
• Be aware of the epidemiology and unique biology of cancer in the AYA population;
• Be familiar of the specialized diagnostic requirements for this type of cancer and appreciate the impact this will have of health services.
-------------------------------------------
|
| |
Back to top |
| |
|
S2421 Advanced Diagnostics Symposium
Tuesday, 1400-1700
|
|
Chairs: David Lebrun, Queen’s University, Kingston, Ontario; Suzanne Kamel-Reid, Princess Margaret Hospital, Toronto, Ontario
|
| |
Back to top |
| |
|
S2422 Forensic Symposium
Tuesday, 1400-1700
|
|
Chair: Michael Pollanen, University of Toronto and Office of the Chief Coroner of Ontario, Toronto, Ontario
|
| |
Back to top |
| |
|
S2423 Neuropathology Symposium
Tuesday, 1400-1700
|
|
Chair: John Woulfe, Ottawa General Hospital, Ottawa, Ontario
|
| 1400-1515 |
How to Take Good Pathology Photographs
Jeff Joseph, University of Calgary, Calgary, Alberta
Click here for Objectives of this presentation
At the end of the session, the participant will:
• Understand the importance of and be able to adjust a digital camera's exposure time, aperture, sensitivity, and white balance in order to optimize gross pathology photography;
• Apply some basic principles of composition to optimize gross photography;
• Examine a photograph's histogram and optimize or correct a photograph's colour;
• Use digital imaging software to optimize pathology photographs for different media (e.g. projection and printing).
-------------------------------------------
|
| 1515-1545 |
Refreshment Break
|
| 1545-1700 |
Perinatal Neuropathology: Common Acquired CNS Lesions and Malformations
Lothar Resch, University of Calgary, Calgary, Alberta
Click here for Objectives of this presentation
At the end of the session, the participant will:
• Identify and diagnose the more common acquired perinatal CNS lesions and explain their pathogenesis.;
• Identify and diagnose the more commons CNS malformations that present in the perinatal period and explain their pathogenesis..
-------------------------------------------
|
| |
Back to top |
| |
|
S2431 Workshop on Media Relations
Tuesday, 1700-1745
|
|
Chair: Vina Alexopoulou, McMaster University, Hamilton, Ontario
|
| |
Back to top |
| |
|
S2432 Exit Competencies in Pathology and Laboratory Medicine for Canadian Medical Graduates
Tuesday, 1745-1830
|
|
Chair: Jason Ford, BC Childrens Hospital, Vancouver, British Columbia
|
| |
Back to top |
| |
|
| |
|
| |
|
Banquet and Awards Presentations
Tuesday, 1900-2200
|
